Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY
Publication
, Journal Article
Levi, M; Levy, JH; Truloff, D
Published in: NEW ENGLAND JOURNAL OF MEDICINE
2011
Duke Scholars
Published In
NEW ENGLAND JOURNAL OF MEDICINE
ISSN
0028-4793
Publication Date
2011
Volume
364
Issue
6
Start / End Page
575 / 576
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Levi, M., Levy, J. H., & Truloff, D. (2011). Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 364(6), 575–576.
Levi, Marcel, Jerrold H. Levy, and David Truloff. “Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY.” NEW ENGLAND JOURNAL OF MEDICINE 364, no. 6 (2011): 575–76.
Levi M, Levy JH, Truloff D. Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2011;364(6):575–6.
Levi, Marcel, et al. “Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY.” NEW ENGLAND JOURNAL OF MEDICINE, vol. 364, no. 6, 2011, pp. 575–76.
Levi M, Levy JH, Truloff D. Safety of Recombinant Activated Factor VII in Randomized Clinical Trials REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2011;364(6):575–576.
Published In
NEW ENGLAND JOURNAL OF MEDICINE
ISSN
0028-4793
Publication Date
2011
Volume
364
Issue
6
Start / End Page
575 / 576
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences